The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
about
Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionHIV-1-specific antibody responses during acute and chronic HIV-1 infectionA neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.HIV and malnutrition: effects on immune system.Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag ProteinIsotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individualsDomestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection
P2860
Q33752804-36473912-4E1E-4EBD-9AD1-2F8E583D6F90Q33827771-007AE64B-764B-42D4-9051-91698F1AC880Q34098372-C5E48E77-B819-4DD5-A17C-614C4C5310DDQ34300812-E6E5B8BD-1738-416E-8AF0-E38496ADFD1BQ35096836-59AE03C0-4C1B-4C33-B216-69878D3C152EQ35274924-F889A4CB-D829-47DF-9A25-8D20D741F582Q35661554-BA934EE5-AC0A-4FEC-8B08-BBCA9F9E5868Q35690562-B1E76EC1-F476-4718-8E1C-9F3252F4193BQ35726702-CF261EFF-E3F7-42CD-A9DA-436A823E7461Q35826668-94BD2E28-3C9D-4EA7-B4E1-3A8D377989FFQ35869579-EBDEB7B1-FFB2-40C2-98CC-EED2CD1A35E2Q37295135-25F55A8F-C8CC-4B2B-8508-828F9E89CE2E
P2860
The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The affinity of IgG antibodies ...... ates with disease progression.
@en
The affinity of IgG antibodies ...... ates with disease progression.
@nl
type
label
The affinity of IgG antibodies ...... ates with disease progression.
@en
The affinity of IgG antibodies ...... ates with disease progression.
@nl
prefLabel
The affinity of IgG antibodies ...... ates with disease progression.
@en
The affinity of IgG antibodies ...... ates with disease progression.
@nl
P2093
P2860
P1476
The affinity of IgG antibodies ...... ates with disease progression.
@en
P2093
Chargelegue D
O'Toole CM
Stanley CM
Steward MW
P2860
P304
P356
10.1111/J.1365-2249.1995.TB05529.X
P577
1995-02-01T00:00:00Z